Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

Share Price is delayed by 15 minutes
Get Live Data
19.50    0.25 (1.30%)
Bid:
19.00
Ask:
20.00
Spread: 1.00 (5.263%)
Market Cap: £17.48m
IHC Live PriceLast checked at - London Stock Exchange

Intraday Inspiration Hlt Share Chart

Corrected rPAP Driver Unit Granted CE mark notice

17 Oct 2017 09:15

RNS Number : 7994T
Inspiration Healthcare Group PLC
17 October 2017
 

17 October 2017

 

 

The following statement has been amended in the "Neonatal Resuscitation Driver Granted CE mark" announcement issued at 7am on 17 October 2017 by Inspiration Healthcare Group PLC under RNS Number: 7473T

 

" rPAPä" Has been amended to "rPAP" 

All other information remains unchanged. The full amended text appears below.

 

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

 

rPAP Neonatal Resuscitation Driver Unit Granted CE mark 

 

 

Inspiration Healthcare Group plc (AIM: IHC), the global supplier of medical technology for critical care, operating theatre and other medical applications, is delighted to announce that the rPAP Driver unit which is an integral part of the Inspire rPAP neonatal resuscitation system has been granted a CE mark* and can now be sold throughout the EU and certain other territories around the world.

 

The unit, which regulates gas flow entering into a resuscitation device, has been entirely designed by Inspiration Healthcare and complements the first of its own designed medical devices sold by the company, the rPAP Generator. The rPAP Driver and rPAP Generator combine to form the Inspire rPAP system.

 

The Drivers are re-usable which presents significant cost benefits to users without stretching limited capital equipment budgets. They are compact, lightweight and portable and when coupled with the rPAP Generator, the system reduces the effort needed to breathe during the first few minutes of life of a baby that needs resuscitation due to difficulties at the time of birth. The system is being used by a number of hospitals in Scandinavia as part of a multicentre clinical trial.

 

Commenting today, Neil Campbell Inspiration Healthcare's Chief Executive Officer said: "We are delighted to get this approval which means we can begin to distribute the products to the many customers who have already indicated their interest.

 

The Inspire rPAP combines many innovative features into one portable, easy to use system and is designed to work with our "LifeStart" neonatal resuscitation platform which is to be used in a wide range of innovative clinical procedures being adopted in neonatal units such as optimal cord clamping."

 

* CE marking is a mandatory conformity marking for certain products sold within the European Economic Area (EEA).

 

 

Enquiries:

 

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Mike Briant, Chief Financial Officer

Tel: 01455 840555

 

Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly, Bobbie Hilliam (NOMAD)

 

Michael Johnson (Sales)

Tel: 0207 397 8900

 

Cadogan PR

Alex Walters

Tel: 07771 713608

 

 

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) is a global supplier of medical technology for critical care, operating theatre and other medical applications. The Company provides high quality innovative products to patients and caregivers around the world that help to improve patient outcomes and efficiencies of healthcare organisations with patient focused customer service and technical support.

 

The Company's own brand of critical care solutions span non-invasive respiratory management, thermoregulation and diagnostics, and patient warming for newborns through to adults in intensive care and the operating theatre, whilst the distribution business supplies solutions to support specialised surgical procedures and infusion therapies.

 

Present in over 50 countries worldwide, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving the quality of life of patients, working in close collaboration with key opinion leaders and stakeholders in the clinical and medical community across the globe.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGMMMGRNNGNZG
Date   Source Headline
24th May 20237:00 amRNSAppointment of Nominated Adviser and Broker
17th May 20237:00 amRNSMello investor conference
4th May 20237:00 amRNSInvestor Day
3rd May 20237:00 amRNSFinal Results
6th Apr 20235:53 pmRNSGrant of Options
3rd Apr 20235:53 pmRNSGrant of Options
31st Mar 20236:27 pmRNSExercise of Options & Issue of Equity
23rd Mar 20237:00 amRNSLaunch of range extension of neonatal ventilators
1st Mar 20237:00 amRNSChange of Website
17th Feb 20232:05 pmRNSTR1 Notification
16th Feb 20237:00 amRNSTrading Update
9th Dec 20222:27 pmRNSTR1 Notification
8th Dec 20221:10 pmRNSTR1 Notification
5th Dec 20227:00 amRNSBoard Changes
30th Nov 202210:28 amRNSDirector / PDMR Dealing
28th Nov 20222:05 pmRNSSecond Price Monitoring Extn
28th Nov 20222:00 pmRNSPrice Monitoring Extension
28th Nov 20229:05 amRNSSecond Price Monitoring Extn
28th Nov 20229:00 amRNSPrice Monitoring Extension
28th Nov 20227:00 amRNSUpdate on Trading
9th Nov 20227:00 amRNSUkraine Order
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
4th Oct 20222:05 pmRNSSecond Price Monitoring Extn
4th Oct 20222:00 pmRNSPrice Monitoring Extension
4th Oct 202211:05 amRNSSecond Price Monitoring Extn
4th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSInterim Results
21st Sep 20227:00 amRNSSignificant Japanese Order
1st Sep 20227:00 amRNSResults date and Investor events
15th Aug 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSCapital Markets Day
30th Jun 202212:58 pmRNSResult of AGM
30th Jun 20227:00 amRNSAGM Statement
10th Jun 20221:00 pmRNSExercise of options and Total Voting Rights
7th Jun 20227:00 amRNS£1.3 million Iraq Order
6th Jun 20227:00 amRNSAnnual Report 2022 and Notice of AGM
24th May 20227:00 amRNSTR1 Notification
20th May 20223:09 pmRNSTR1 Notification
19th May 20227:00 amRNSMello Investor Conference
4th May 20227:00 amRNSFinal Results
25th Apr 20227:05 amRNSInvestor Presentation
8th Apr 20222:21 pmRNSGrant of Options
1st Apr 20227:00 amRNSLaunch of test to avoid hearing loss in neonates
17th Feb 20227:00 amRNSPost Period Trading Update and Notice of Results
14th Feb 20227:00 amRNS$1.37 million Egyptian Order
1st Feb 20229:00 amRNSCenkos Virtual Growth and Innovation Forum
9th Dec 20214:15 pmRNSTR1 Notification
9th Dec 20214:15 pmRNSTR1 Notification
2nd Dec 20217:00 amRNSCapital Markets Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.